$74.99
0.27% day before yesterday
NYSE, May 23, 10:14 pm CET
ISIN
US28176E1082
Symbol
EW

Edwards Lifesciences Stock price

$74.99
+4.53 6.43% 1M
+3.72 5.22% 6M
+0.96 1.30% YTD
-12.47 14.26% 1Y
-21.14 21.99% 3Y
+2.05 2.82% 5Y
+53.18 243.78% 10Y
NYSE, Closing price Fri, May 23 2025
+0.20 0.27%
ISIN
US28176E1082
Symbol
EW
Sector

Key metrics

Market capitalization $43.99b
P/E (TTM) P/E ratio 10.55
P/S ratio (TTM) P/S ratio 7.94
Revenue growth (TTM) Revenue growth -6.00%
Revenue (TTM) Revenue $5.54b
EBIT (operating result TTM) EBIT $1.53b
EPS (TTM) EPS $7.11
P/E forward 30.56
P/S forward 7.45
Short interest 1.60%
Show more

Is Edwards Lifesciences a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Edwards Lifesciences Stock Analysis

Unlock Scores for Free

Analyst Opinions

32 Analysts have issued a Edwards Lifesciences forecast:

16x Buy
50%
15x Hold
47%
1x Sell
3%

Analyst Opinions

32 Analysts have issued a Edwards Lifesciences forecast:

Buy
50%
Hold
47%
Sell
3%

Financial data from Edwards Lifesciences

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
5,539 5,539
6% 6%
100%
- Direct Costs 1,142 1,142
15% 15%
21%
4,397 4,397
3% 3%
79%
- Selling and Administrative Expenses 1,830 1,830
0% 0%
33%
- Research and Development Expense 1,052 1,052
2% 2%
19%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 1,535 1,535
9% 9%
28%
Net Profit 4,181 4,181
196% 196%
75%

In millions USD.

Don't miss a Thing! We will send you all news about Edwards Lifesciences directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Edwards Lifesciences Stock News

Neutral
Business Wire
3 days ago
PARIS--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced new economic and clinical evidence on severe aortic stenosis (AS) presented as a late-breaking clinical trial at EuroPCR 2025, further contributing to the extensive body of research on this disease. The results of a new real-world study of more than 24,000 patients demonstrated that intervening on the disease before symptom...
Neutral
Business Wire
19 days ago
IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced it will participate in the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025. Bernard Zovighian, chief executive officer, and Scott Ullem, chief financial officer, will participate in a fireside chat at 10:40 a.m. Pacific Time. A live webcast of the discussion will be available on the Edwards Lif...
Neutral
Seeking Alpha
about one month ago
Edwards Lifesciences Corporation (NYSE:EW ) Q1 2025 Earnings Conference Call April 23, 2025 5:00 PM ET Company Participants Mark Wilterding - SVP, Global Finance Bernard Zovighian - CEO Scott Ullem - CFO Daveen Chopra - Global Leader, TMTT Larry Wood - Global Group President, TAVR and Surgical Conference Call Participants Larry Biegelsen - Wells Fargo David Roman - Goldman Sachs Travis Steed - ...
More Edwards Lifesciences News

Company Profile

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart and Critical Care. The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. Its portfolio includes technologies designed for nonsurgical replacement of heart valves. The Surgical Structural Heart portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The Critical Care portfolio products through hemodynamic monitoring system measures a patient's heart function and fluid status in surgical and intensive care settings. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Head office United States
CEO Bernard Zovighian
Employees 15,800
Founded 1958
Website www.edwards.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today